Zevra Therapeutics Inc. (ZVRA)
Healthcare
Biotechnology
9.50 $
-1.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Zevra Therapeutics Inc. (ZVRA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 92.9% of the shares are freely tradable; institutional investors hold 71.8%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
71.8%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
1.3%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
92.9%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
11.2%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
59Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 7.54 | 4,456,476 | -1.1 | 03/31/2026 |
| Woodline Partners LP | 5.84 | 3,450,943 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 5.59 | 3,305,207 | +7.2 | 12/31/2025 |
| FMR Inc | 5.43 | 3,211,877 | +34.2 | 03/31/2026 |
| Nantahala Capital Management, LLC | 4.27 | 2,521,936 | +42.3 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.18 | 2,469,328 | +0.0 | 03/31/2026 |
| State Street Corp | 2.64 | 1,561,569 | +5.3 | 03/31/2026 |
| Geode Capital Management, LLC | 2.32 | 1,371,857 | +2.2 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Contrafund | 4.15 | 2,454,673 | +31.0 | 04/30/2026 |
| Vanguard Total Stock Mkt Idx Inv | 2.99 | 1,769,506 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.